The role of neoadjuvant chemotherapy in advanced Ovarian Cancer (AOC):
Avoiding ‘needless hurt’ or a Trojan horse?
- Robert Armbrust,
- Christina Fotopoulou
, - Jalid Sehouli
Robert Armbrust
Charite Universitatsmedizin Berlin - Campus Virchow-Klinikum
Corresponding Author:robert.armbrust@charite.de
Author ProfileChristina Fotopoulou
Charite Universitatsmedizin Berlin - Campus Virchow-Klinikum
Author ProfileJalid Sehouli
Charite Universitatsmedizin Berlin - Campus Virchow-Klinikum
Author Profile09 Aug 2023Submitted to BJOG: An International Journal of Obstetrics and Gynaecology 10 Aug 2023Submission Checks Completed
10 Aug 2023Assigned to Editor
10 Aug 2023Review(s) Completed, Editorial Evaluation Pending
21 Aug 2023Editorial Decision: Revise Minor
22 Aug 20231st Revision Received
23 Aug 2023Submission Checks Completed
23 Aug 2023Assigned to Editor
23 Aug 2023Review(s) Completed, Editorial Evaluation Pending
21 Oct 2023Editorial Decision: Accept
